Randox Health Cancer screening

Bowel Cancer Risk Test

A genetic blood test screening 13 genes linked to inherited bowel cancer risk, with a results consultation, for anyone with a family history of the disease.

  • Doctor reviewed
Sample
Blood
Collection
Venous draw at clinic
Results in
42 days
Biomarkers
13
Doctor reviewed
Yes
Tests for
  • APC
  • BMPR1A
  • EPCAM
  • MLH1
  • MSH2
  • MSH6
  • MUTYH
  • PMS2
  • POLD1
  • POLE
  • PTEN
  • SMAD4
  • +1 more

Test specifications

Provider
Randox Health
Sample type
blood
Collection method
venous draw at clinic
Turnaround time
42 days
Biomarkers tested
13
At-home test
No
Doctor reviewed
Yes
Gender focus
Both

What's tested

13 biomarkers as listed by Randox Health.

  • APC
  • BMPR1A
  • EPCAM
  • MLH1
  • MSH2
  • MSH6
  • MUTYH
  • PMS2
  • POLD1
  • POLE
  • PTEN
  • SMAD4
  • STK11

About this test

This test looks for mutations in 13 genes associated with an increased inherited risk of bowel cancer. Genetic testing like this is commonly used to assess risk rather than to diagnose cancer itself; the provider notes that most people with an inherited mutation will not develop symptoms early on.

With 13 biomarkers, it sits toward the higher end for clinical depth among the cancer screening tests we track. There are no named peer tests in our data for this specific panel, so we cannot say whether its £594 price is high or low relative to similar genetic panels, though the scoring reflects that gap in comparable data rather than a judgement either way.

It scores well for results and follow-up, since results are reviewed by a doctor as part of a consultation, and includes access to a genetic counsellor beforehand. It scores lower for collection convenience, given the venous draw and the roughly 6-week turnaround.

Who is it for?

This suits people with a family history of bowel cancer, such as a parent or sibling diagnosed with the condition, who want to understand their inherited genetic risk with expert guidance built in. The provider offers a £100 genetic counselling call beforehand, which is deducted from the cost if you go ahead. This is a significant financial commitment, so it is worth discussing with your GP whether genetic testing is appropriate for your family history first.

How it works

A blood sample is taken by venous draw at a Randox clinic and analysed for mutations across 13 genes. The provider states it will make contact within 6 weeks to arrange a results consultation, and results are reviewed by a doctor as part of that process.

Pros & cons

Pros

  • Screens 13 genes linked to inherited bowel cancer risk
  • Results are reviewed by a doctor as part of a consultation
  • Includes access to a genetic counsellor before testing

Cons

  • Results take around 6 weeks to come back
  • At £594, this is a significant cost with no comparable tests in our data to benchmark it against
  • Requires a venous draw at a clinic

Our editorial score

Compare Health Test Score 13-gene bowel cancer panel, doctor-reviewed, 6-week wait
Editorial confidence: 10.0/10

This £594 genetic test screens 13 genes associated with inherited bowel cancer risk and includes a doctor-reviewed results consultation, though results take around 6 weeks. There are no directly comparable named tests in our data, so we cannot say how its price compares with similar panels.

Score breakdown

  • Clarity and documentation 9.0/10

    The listing publishes a detailed description, the full biomarker list, a stated turnaround, clear collection options, the sample type; it does not state what the report looks like.

  • Clinical depth 9.2/10

    13 biomarkers, placing it in the 79th percentile of cancer screening tests we track.

  • Collection convenience 3.0/10

    Requires a venous draw at a clinic; results in around 42 days, slower than similar tests.

  • Results and follow-up 7.0/10

    Results are reviewed by a doctor; the provider does not describe the report format.

  • Trust signals 9.0/10

    Trustpilot 4.6 from 29,705 reviews; accredited lab (UKAS ISO 15189 (Randox Clinical Laboratory Services, lab 9329)); CQC registered.

  • Value for money 6.0/10

    £594.00; no comparable tests to benchmark against yet.

Calculated 13 September 2026 from the facts we hold about this test and provider, using our published scoring formula. Scores are not hand-edited.

More in Cancer screening

View all →
Selph

qFIT Bowel Cancer Screening Test

Priced close to the FIT test group median

A stool test using the qFIT method to measure blood in a stool sample, giving a numerical result rather than a simple positive or negative. Suited to adults wanting to check a common early indicator of possible bowel cancer risk.

  • At-home test
8.1 / 10
£59.00
Full review →